Calcineurin inhibitors have become a pillar of immunosuppressive treatment in solid organ transplant recipients. Several case reports have shown hypertrophic and dilated cardiomyopathy as an adverse effect to tacrolimus therapy. We present the case of a kidney transplant recipient woman who developed hypertrophic cardiomyopathy due to tacrolimus therapy.

Retos de las unidades renales frente a la pandemia por el virus SARS-CoV-2 Challenges of renal facilities facing SARS-CoV-2 virus pandemic

In receptors of solid organ transplant, calcineurin inhibitors has become a pillar of immunosuppressive treatment. Several case reports have shown hypertrophic and dilated cardiomyopathy as a side effect of tacrolimus. We present the case of a woman receptor of a kidney transplant who developed hypertrophic cardiomyopathy due to Tacrolimus.